Common Contracts
6 similar Stock Repurchase Agreement contracts by Ades Alan A., Organogenesis Holdings Inc.
STOCK REPURCHASE AGREEMENTStock Repurchase Agreement • November 14th, 2024 • Ades Alan A. • Pharmaceutical preparations • Delaware
THIS STOCK REPURCHASE AGREEMENT (this “Agreement”) is entered into as of November 12, 2024, by and between Organogenesis Holdings Inc., a Delaware corporation (the “Company”), and the Alan Ades 2014 GRAT (the “Selling Stockholder”).
STOCK REPURCHASE AGREEMENTStock Repurchase Agreement • November 14th, 2024 • Ades Alan A. • Pharmaceutical preparations • Delaware
THIS STOCK REPURCHASE AGREEMENT (this “Agreement”) is entered into as of November 12, 2024, by and between Organogenesis Holdings Inc., a Delaware corporation (the “Company”), and Albert Erani (the “Selling Stockholder”).
STOCK REPURCHASE AGREEMENTStock Repurchase Agreement • November 14th, 2024 • Ades Alan A. • Pharmaceutical preparations • Delaware
THIS STOCK REPURCHASE AGREEMENT (this “Agreement”) is entered into as of November 12, 2024, by and between Organogenesis Holdings Inc., a Delaware corporation (the “Company”), and Alan A. Ades (the “Selling Stockholder”).
STOCK REPURCHASE AGREEMENTStock Repurchase Agreement • November 14th, 2024 • Ades Alan A. • Pharmaceutical preparations • Delaware
THIS STOCK REPURCHASE AGREEMENT (this “Agreement”) is entered into as of November 12, 2024, by and between Organogenesis Holdings Inc., a Delaware corporation (the “Company”), and RED Holdings, LLC (the “Selling Stockholder”).
STOCK REPURCHASE AGREEMENTStock Repurchase Agreement • November 14th, 2024 • Ades Alan A. • Pharmaceutical preparations • Delaware
THIS STOCK REPURCHASE AGREEMENT (this “Agreement”) is entered into as of November 12, 2024, by and between Organogenesis Holdings Inc., a Delaware corporation (the “Company”), and Glenn H. Nussdorf (the “Selling Stockholder”).
STOCK REPURCHASE AGREEMENTStock Repurchase Agreement • November 13th, 2024 • Organogenesis Holdings Inc. • Pharmaceutical preparations • Delaware
THIS STOCK REPURCHASE AGREEMENT (this “Agreement”) is entered into as of November 12, 2024, by and between Organogenesis Holdings Inc., a Delaware corporation (the “Company”), and [_______________] (the “Selling Stockholder”).
